14q3

Targeting Trends 2014 Newsletter

2014, issue 1: FDA Gives Green Light to Human Clinical Trials for Cancer Pain / by DA Lappi / featuring SP-SAP Targeting Talk: Time Course Targeting Tools: Investigating the Itch Pathway 2014, issue 2: Celebrating Twenty Years of Science Advanced Targeting Systems (founded 22 Apr 1994) / featuring 192-IgG-SAP, SP-SAP, Bombesin-SAP Celebrating Twenty Years of People Who Make ATS …

Targeting Trends 2014 Newsletter Read More »

Welcome to little Kermit.

Welcome to little Kermit. He knows he has Gangsta’s big paws to fill, but Kermit seems to be trying his best!

Targeting Topics 14q3

Role for monocyte chemoattractant protein-1 in the induction of chronic muscle pain in the rat. Alvarez P, Green PG, Levine JD. Pain 155(6):1161-1167, 2014. In order to better understand where monocyte chemoattractant protein 1 (MCP-1) fits in the chronic pain landscape the authors performed a series of experiments using antisense and mismatch oligodeoxynucleotides against the …

Targeting Topics 14q3 Read More »

Cover Article: Corticotropin releasing factor-saporin conjugate selectively lesions nucleus incertus.

Contributed by Corinne Liying Lee, Ramamoorthy Rajkumar, Gavin Stewart Dawe, Department of Pharmacology, Yong Loo Lin School of Medicine, National University Health System; Neurobiology and Ageing Programme, Life Sciences Institute, National University of Singapore; and Singapore Institute for Neurotechnology (SINAPSE), Singapore 117456 The nucleus incertus (NI) is a distinct group of cells in the pontine …

Cover Article: Corticotropin releasing factor-saporin conjugate selectively lesions nucleus incertus. Read More »